Effect of rTMS in treatment of generalized anxiety disorder

Comparison of the effectiveness of rTMS device with drug therapy on the improvement of cognitive impairment in patients with generalized anxiety disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210328050785N1

Enrollment

Registered

2021-08-02

Start date

2021-07-18

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder. Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: 10 sessions of treatment with repetitive transcranial magnetic stimulation (rTMS) over 2 weeks (5 days per week). Each treatment session will last about 45 minutes

Eligibility

Sex/Gender

All

Age

15 Years to 55 Years

Inclusion criteria

Inclusion criteria: Patients with generalized anxiety disorder in the age range of 15-55 years Patients agree to enter the study The first action of patients in the treatment of their disease

Exclusion criteria

Exclusion criteria: Age under 15 or over 55 years Existence of metal accessories or prostheses in the body Traditional or industrial drug addiction Having comorbid disease such as diabetes and high blood pressure Severe anxiety and restlessness or severe insomnia Taking any medication in the patient's history

Design outcomes

Primary

Measure	Time frame
Cognitive impairment score in ( MMSE) Mini-Mental State Exam, cognitive impairment test. Timepoint: Measurement of cognitive impairment score (before the start of the study) and 2 and 4 weeks after the end of the study. Method of measurement: MMSE Cognitive Disorder Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahtab Meydani

Islamic Azad University

mahtabmeydani2014@gmail.com+98 35 3725 1785

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026